Literature DB >> 17230492

Maternal serum screening and 22q11.2 deletion syndrome.

Michael L Begleiter, Molly M Lund, Andrea M Atherton, Janda D Buchholz, Holly H Ardinger.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17230492     DOI： 10.1002/ajmg.a.31616

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN： 1552-4825            Impact factor:   2.802


× No keyword cloud information.
  1 in total

1.  Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele.

Authors:  Jodi D Hoffman; Diana W Bianchi; Lisa M Sullivan; Brenda L Mackinnon; Jamie Collins; Fergal D Malone; T Flint Porter; David A Nyberg; Christine H Comstock; Radek Bukowski; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'Alton
Journal:  Prenat Diagn       Date:  2008-12       Impact factor: 3.050
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.